Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease
Jeffrey W. Pippin, … , Oliver Wessely, Stuart J. Shankland
Jeffrey W. Pippin, … , Oliver Wessely, Stuart J. Shankland
Published August 15, 2022
Citation Information: J Clin Invest. 2022;132(16):e156250. https://doi.org/10.1172/JCI156250.
View: Text | PDF
Research Article Aging

Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease

  • Text
  • PDF
Abstract

With an aging population, kidney health becomes an important medical and socioeconomic factor. Kidney aging mechanisms are not well understood. We previously showed that podocytes isolated from aged mice exhibit increased expression of programmed cell death protein 1 (PD-1) surface receptor and its 2 ligands (PD-L1 and PD-L2). PDCD1 transcript increased with age in microdissected human glomeruli, which correlated with lower estimated glomerular filtration rate and higher segmental glomerulosclerosis and vascular arterial intima-to-lumen ratio. In vitro studies in podocytes demonstrated a critical role for PD-1 signaling in cell survival and in the induction of a senescence-associated secretory phenotype. To prove PD-1 signaling was critical to podocyte aging, aged mice were injected with anti–PD-1 antibody. Treatment significantly improved the aging phenotype in both kidney and liver. In the glomerulus, it increased the life span of podocytes, but not that of parietal epithelial, mesangial, or endothelial cells. Transcriptomic and immunohistochemistry studies demonstrated that anti–PD-1 antibody treatment improved the health span of podocytes. Administering the same anti–PD-1 antibody to young mice with experimental focal segmental glomerulosclerosis (FSGS) lowered proteinuria and improved podocyte number. These results suggest a critical contribution of increased PD-1 signaling toward both kidney and liver aging and in FSGS.

Authors

Jeffrey W. Pippin, Natalya Kaverina, Yuliang Wang, Diana G. Eng, Yuting Zeng, Uyen Tran, Carol J. Loretz, Anthony Chang, Shreeram Akilesh, Chetan Poudel, Hannah S. Perry, Christopher O’Connor, Joshua C. Vaughan, Markus Bitzer, Oliver Wessely, Stuart J. Shankland

×

Figure 8

Changes to podocyte canonical genes, proteins, and transcription factors.

Options: View larger image (or click on image) Download as PowerPoint
Changes to podocyte canonical genes, proteins, and transcription factors...
(A) Expression of individual canonical podocyte genes from mRNA-Seq data of young mice (Y, gray bars), aged mice injected with IgG2a (red bars), and aged mice injected with anti–PD-1 antibody (αPD1, blue bars). The levels of all genes were lower in aged IgG2a-injected mice compared with young mice, and all except Ptpro were increased in aPD1ab-injected mice. TPM, transcripts per million. (B–M) Protein validation of select genes by immunostaining. Representative immunoperoxidase staining for nephrin (B–D, brown), immunofluorescent staining for synaptopodin (F–H, green), and immunoperoxidase staining for VEGFA (J–L, black). The box in each panel shows an example of a glomerulus. Bar graphs show the quantification of nephrin (E), synaptopodin (I), and VEGFA (M) staining with each circle representing an individual mouse. Compared with young mice (gray bars), immunostaining was lower for each in aged IgG2a-injected mice (red bars) but was higher in aged aPD1ab-injected mice (blue bars). (N) VIPER (virtual inference of protein activity by enriched regulon) analysis of transcription factor activity. The top 10 transcription factors impacted by aPD1ab treatment are shown in the third column, along with their significance (first column), representative activity (second column), conferred activity (fourth column), and expression (fifth column), with red showing increased and blue decreased levels/activities. The conferred activity of Hnf1b, Nr2f6, Mbd3, and Tada2b increased, with increased expression. Zfp39, Sall1, and Sox7 activity was decreased despite higher expression levels in aPD1ab-injected mice. While the lower activity of Ets1 and the lower activity of Tcf4 were independent of their expression levels, the lower activity of Zeb2 correlated with its lower expression. Scale bars represent 50 μm (B–D and J–L) and 100 μm (F–H). Statistical analysis was performed by t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts